Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models
Xiao Yu Wu(University of Toronto), Liang Shen(Shandong University of Technology), Guan Nan Wu(Nanjing Traditional Chinese Medicine Hospital), Hao Xu(Lianyungang Maternal and Children’s Hospital), Gang Li(Qiqihar Medical University), Che Chen(Gansu University of Traditional Chinese Medicine), Zhen Wu(Nanjing Traditional Chinese Medicine Hospital), Fu Kun Liu(Nanjing Traditional Chinese Medicine Hospital), Jia Yun Liu(Nanjing Traditional Chinese Medicine Hospital), Xue Quan Yao(Nanjing Traditional Chinese Medicine Hospital)
Cited by 85
Related Papers
Nanomedicine in pulmonary delivery
|International Journal of Nanomedicine|2009|470
The pharmacology of curcumin: is it the degradation products?
|Trends in Molecular Medicine|2012|299
Alzheimer’s Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
|Journal of Alzheimer s Disease|2016|280
Theoretical study on physicochemical properties of curcumin
|Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy|2006|220
Comparative study of copper(II)–curcumin complexes as superoxide dismutase mimics and free radical scavengers
|European Journal of Medicinal Chemistry|2006|163